Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Peter Nash, Kamal Ohson, Jessica Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J Gómez-Reino, Jacob A Aelion
  • Annals of the Rheumatic Diseases, January 2018, BMJ
  • DOI: 10.1136/annrheumdis-2017-211568

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1136/annrheumdis-2017-211568

The following have contributed to this page: Professor Antonio Fernandez-Nebro